Epix To Advance COPD, Alzheimer’s Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm moving ahead after failed depression trial.
You may also be interested in...
GSK/Epix Alzheimer’s Drug Starts Phase IIb
Firm tries again with PRX-03140/donepezil combo.
Epix Looks To Partner With Path Now Clear For Vasovist Approval
Epix will file an NDA in mid-2008 following positive results from reevaluation of the vascular imaging agent.
Epix Drops Depression Candidate After Second Study Failure
Alzheimer’s candidate in development with GlaxoSmithKline advances.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: